Performance Measurement of Medicines Delivery of Pharmaceutical Companies Under Chain of Sustainable Procurement

In: International journal of social ecology and sustainable development: IJSESD ; an official publication of the Information Resources Management Association, Band 10, Heft 3, S. 116-128

Abstract

Pharmaceuticals companies manufacture and maintain the stocks of several medicines. Presently, hospitals maintain stock to supply the appropriate medicine to patients under their care. The availability of medicines is dependent on the service level of suppliers. In last decade, the pharmaceutical supply chains have been an increasingly important topic. Pharmaceutical supply chains of the medicine manufacturing firm are based on traditional supply chain strategies. But, the concept became obsolete, replaced by modern supply chain strategy. The modern supply chain better analyzes pharmaceutical architectures such as green, service, agile, resilient, flexible manufacturing and is called the pharmaceutical G-F-A-L-R supply chain. To evolve a new model for the pharmaceutical supply chain, a 2nd second level pharmaceutical hierarchy G-F-A-L-R supply chain module structure has been constructed, where a Fuzzy Performance Index model has been applied on the module to compute the overall performance of individual pharmaceutical companies.